Acquisition Momentum Cantel Medical is now part of STERIS after a high-value acquisition, indicating consolidation in the infection prevention space. This presents cross-sell opportunities to STERIS customers and access to an expanded global installed base for infection control products and services.

Integrated Portfolio Recent acquisitions (Hu-Friedy, Omnia) suggest Cantel aims to broaden dental and infection prevention offerings. A sales approach can emphasize bundled solutions across sterilization, disinfection, and dental consumables to improve workflow efficiency for healthcare facilities.

Infection Prevention Focus Cantel specializes in infection prevention products and services. This focus aligns with ongoing hospital and clinic demand for advanced reprocessing, endoscope maintenance, and compliant sterilization solutions, signaling opportunities for core product upsells and service contracts.

Digital & Tech Enablement The tech stack includes iCIMS, Google Analytics, and Squarespace, indicating mature digital operations and potential for data-driven outreach, targeted marketing programs, and digital onboarding of new customers for faster sales cycles.

Strategic Partnerships Past collaboration on endoscope reprocessing software and ongoing integration efforts imply openness to technology partners and smart service solutions. This creates avenues for channel partnerships, joint ventures, and interoperability integrations to expand market reach.